Prostate cancer in dogs and men: A unique opportunity to study the disease

Veterinary Journal

Volumn 180, Issue 2, 2009, Pages 137-138

  Argyle, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARGININE ESTERASE; BISPHOSPHONIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; ANTIGEN DETECTION; AWARENESS; BONE METASTASIS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DOG DISEASE; EARLY DIAGNOSIS; EDITORIAL; EUTHANASIA; GAIT DISORDER; HEALTH EDUCATION; HUMAN; LOW BACK PAIN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY OF LIFE; SURVIVAL TIME;

ANIMALS; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; HUMANS; MALE; PROSTATIC NEOPLASMS;

CANIS FAMILIARIS;

EID: 61749086698     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.08.012     Document Type: Editorial

References (5)

1. Hernandez J., and Thompson I.M. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 101 (2004) 894-904
2. Khanna C., Lindblad-Toh K., Vail D., London C., Bergman P., Barber L., Breen M., Kitchell B., McNeil E., Modiano J.F., Niemi S., Comstock K.E., Ostrander E., Westmoreland S., and Withrow S. The dog as a cancer model. Nature Biotechnology 24 (2006) 1065-1066
3. Lai C.L., van den Ham R., van Leenders G., and Teske E. Histopathological and immunohistochemical characterization of canine prostate cancer. Prostate 68 (2008) 477-488
4. LeRoy, B., Northrup, N., 2009. Prostate cancer in companion animals: comparative and clinical aspects. The Veterinary Journal 180, 149-162.
5. Zynger D.L., Dimov N.D., Catalona W.J., and Yang X.J. Increasing incidence of no residual and low volume prostate cancer: a study of 1792 radical prostatectomies. Journal of Urology 179 (2008) 688-689